(Q83425478)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Emma Glamuzina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Emma Fettes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Katie Bainbridge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Victoria Crook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Niamh Finnegan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lara Abulhoul

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ashok Vellodi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

16 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

749-754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327479%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-011-9280-1

22 January 2020

exact match

0 references

cites work

Six-minute walk test in children with chronic conditions

1 reference

12 December 2020

Changes in gait pattern as assessed by the GAITRite™ walkway system in MPS II patients undergoing enzyme replacement therapy

1 reference

12 December 2020

Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).

1 reference

12 December 2020

Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses

1 reference

12 December 2020

Choosing the best endpoint

1 reference

12 December 2020

Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests

1 reference

12 December 2020

Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS

1 reference

12 December 2020

1 reference

12 December 2020

Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II.

1 reference

12 December 2020

Lung function in white children aged 4 to 19 years: I--Spirometry

1 reference

12 December 2020

Initial report from the Hunter Outcome Survey

1 reference

12 December 2020

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease

1 reference

12 December 2020

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

The 6-minute walk test: normal values for children of 4-11 years of age

1 reference

12 December 2020

The EPICure study: comparison of pediatric spirometry in community and laboratory settings

1 reference

12 December 2020